Insulin aspart (B28 Asp-insulin): A fast-acting analog of human insulin: Absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects

Diabetes Care

Volumn 22, Issue 9, 1999, Pages 1501-1506

  Mudaliar, Sunder R ^b   Lindberg, Fedon A ^b   Joyce, Mary ^b   Beerdsen, Patricia ^b   Strange, Poul ^b   Lin, Alan ^b   Henry, Robert R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; NOVOLIN ASPART; UNCLASSIFIED DRUG;

ABDOMEN; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DELTOID MUSCLE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; HUMAN; HUMAN EXPERIMENT; MALE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THIGH;

ABSORPTION; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; REFERENCE VALUES;

EID: 0032841674     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.9.1501     Document Type: Article

References (19)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 28:103-117, 1995
3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
4. Bhaskar PT, Chou MCY, Field JB: Time action characteristics of regular and NPH insulin in insulin-treated diabetics. J Clin Endocrinol Metab 50:475-479, 1980
5. Dimitriadis GD, Gerich JE: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1983
6. Lean MJE, Ng LL, Tennison BR: Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J 290:105-108, 1985
7. Patrick AW, Collier A, Mathews DM, Macintyre CCA, Clarke BF: The importance of the time interval between insulin injection and breakfast in determining post prandial glycemic control: a comparison between human and pork insulin. Diabet Med 5:32-35, 1988
8. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro (B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
9. Kang S, Brange J, Burch A, Volund A, Owens DR: Subcutaneous insulin absorption explained by insulin's physicochemical properties: evidence from absorption studies of soluble human insulin and insulin analogues in humans. Diabetes Care 14: 942-948, 1991
10. Drejer K, Kruse V, Larsen UD, Hougaard P, Bjorn S, Gammeltoft S: Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma Hep G2 cells. Diabetes 40:1488-1495, 1991
11. Drejer K: The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 8:259-286, 1992
12. B28) in healthy subjects. Diabetes Care 14:1057-1065, 1991
13. Bantle JP, Lonzette N, Frankamp LM: Effects of anatomical region used for insulin injections on glycemia in type 1 diabetes subjects. Diabetes Care 16:1592-1597, 1993
14. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
15. Braak EW, Woodward JR, Rutgert B, Cerimele B, Erkelens DW, Thijssen JHH, Kurtz D: Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin. Diabetes Care 12: 1437-1440, 1996
16. Vora JP, Burch A, Peters JR, Owens DR: Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 15:1484-1493, 1992
17. Berger M, Cuppers HJ, Hegner H, Jorgens V, Berchthold P: Absorption kinetics and biological effects of subcutaneously injected insulin preparations. Diabetes Care 5:77-91, 1982
18. 131I from the subcutaneous tissues in normal and diabetic subjects. Lancet i:964-967, 1959
19. Witt MF, White NH, Santiago JV: Role of site and timing of the morning insulin injection in type I diabetes. J Pediatr 103:528-533, 1983